These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 17872472)
1. Interferon-gamma and intimal hyperplasia. Rose ML Circ Res; 2007 Sep; 101(6):542-4. PubMed ID: 17872472 [No Abstract] [Full Text] [Related]
2. Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Wang Y; Bai Y; Qin L; Zhang P; Yi T; Teesdale SA; Zhao L; Pober JS; Tellides G Circ Res; 2007 Sep; 101(6):560-9. PubMed ID: 17656678 [TBL] [Abstract][Full Text] [Related]
3. Unique, highly proliferative growth phenotype expressed by embryonic and neointimal smooth muscle cells is driven by constitutive Akt, mTOR, and p70S6K signaling and is actively repressed by PTEN. Mourani PM; Garl PJ; Wenzlau JM; Carpenter TC; Stenmark KR; Weiser-Evans MC Circulation; 2004 Mar; 109(10):1299-306. PubMed ID: 14993145 [TBL] [Abstract][Full Text] [Related]
4. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924 [TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459 [TBL] [Abstract][Full Text] [Related]
6. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. Salh B; Wagey R; Marotta A; Tao JS; Pelech S J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729 [TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway. Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193 [TBL] [Abstract][Full Text] [Related]
8. PPARĪ³ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells. Zhang LL; Gao CY; Fang CQ; Wang YJ; Gao D; Yao GE; Xiang J; Wang JZ; Li JC Cardiovasc Res; 2011 Dec; 92(3):484-93. PubMed ID: 21880694 [TBL] [Abstract][Full Text] [Related]
9. The cyclolignan picropodophyllin attenuates intimal hyperplasia after rat carotid balloon injury by blocking insulin-like growth factor-1 receptor signaling. Razuvaev A; Henderson B; Girnita L; Larsson O; Axelson M; Hedin U; Roy J J Vasc Surg; 2007 Jul; 46(1):108-15. PubMed ID: 17606126 [TBL] [Abstract][Full Text] [Related]
10. Rapamycin plays a new role as differentiator of vascular smooth muscle phenotype. focus on "The mTOR/p70 S6K1 pathway regulates vascular smooth muscle differentiation". Lucchesi PA Am J Physiol Cell Physiol; 2004 Mar; 286(3):C480-1. PubMed ID: 14761882 [No Abstract] [Full Text] [Related]
11. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. Bishop JD; Nien WL; Dauphinee SM; Too CK J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564 [TBL] [Abstract][Full Text] [Related]
12. Adenoviral activin A expression prevents vein graft intimal hyperplasia in a rat model. Kloppenburg GT; Grauls GE; Bruggeman CA; Stassen FR Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):31-4. PubMed ID: 18854336 [TBL] [Abstract][Full Text] [Related]
13. Antirestenotic mechanisms of everolimus on human coronary artery smooth muscle cells: inhibition of human coronary artery smooth muscle cell proliferation, but not migration. Lavigne MC; Grimsby JL; Eppihimer MJ J Cardiovasc Pharmacol; 2012 Feb; 59(2):165-74. PubMed ID: 21983747 [TBL] [Abstract][Full Text] [Related]
14. Serotonin-induced growth of pulmonary artery smooth muscle requires activation of phosphatidylinositol 3-kinase/serine-threonine protein kinase B/mammalian target of rapamycin/p70 ribosomal S6 kinase 1. Liu Y; Fanburg BL Am J Respir Cell Mol Biol; 2006 Feb; 34(2):182-91. PubMed ID: 16195541 [TBL] [Abstract][Full Text] [Related]
15. [Current problems in the pathological anatomy of coronary atherosclerosis]. Zhdanov VS Arkh Patol; 1993; 55(2):58-63. PubMed ID: 7980065 [TBL] [Abstract][Full Text] [Related]
16. Origin of the smooth muscle cells in intimal hyperplasia: do we come to the end of the tunnel? Beranek JT J Heart Lung Transplant; 1993; 12(1 Pt 1):152-4. PubMed ID: 8318075 [No Abstract] [Full Text] [Related]
17. Interferon-gamma plays a nonredundant role in mediating T cell-dependent outward vascular remodeling of allogeneic human coronary arteries. Wang Y; Burns WR; Tang PC; Yi T; Schechner JS; Zerwes HG; Sessa WC; Lorber MI; Pober JS; Tellides G FASEB J; 2004 Mar; 18(3):606-8. PubMed ID: 14734640 [TBL] [Abstract][Full Text] [Related]
18. LY303511 (2-piperazinyl-8-phenyl-4H-1-benzopyran-4-one) acts via phosphatidylinositol 3-kinase-independent pathways to inhibit cell proliferation via mammalian target of rapamycin (mTOR)- and non-mTOR-dependent mechanisms. Kristof AS; Pacheco-Rodriguez G; Schremmer B; Moss J J Pharmacol Exp Ther; 2005 Sep; 314(3):1134-43. PubMed ID: 15923340 [TBL] [Abstract][Full Text] [Related]